The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Search for "psoriasis"

Search results for: psoriasis

Mirikizumab Promising for Plaque Psoriasis

April 10, 2019 • By Michele B. Kaufman, PharmD, BCGP

During a 16-week study, patients with plaque psoriasis taking mirikizumab experienced higher response rates and skin clearance compared with placebo…... [Read More]

Filed Under: Biologics & Biosimilars, Drug Updates Tagged With: mirikizumab, plaque psoriasis, skin

For Psoriasis, Ustekinumab & TNF Inhibitors Show Similar Cardiac Safety

April 9, 2019 • By David Douglas

NEW YORK (Reuters Health)—In patients with psoriasis and psoriatic arthritis, the incidence of atrial fibrillation and major adverse cardiovascular events does not differ between treatment with ustekinumab and TNF inhibitors, according to a large observational study. “Given a high cardiovascular risk among patients with psoriasis and psoriatic arthritis,” Seoyoung C. Kim, MD, ScD, MSCE, told… [Read More]

Filed Under: Conditions Tagged With: cardiovascular, cardiovascular event, Psoratic Arthritis, Psoriasis, Safety, TNF inhibitor, ustekinumab

FDA Update: Topical Plaque Psoriasis Treatment Approved; Dupilumab Will Receive FDA Priority Review

December 3, 2018 • By Michele B. Kaufman, PharmD, BCGP

The FDA has approved halobetasol propionate lotion as a topical treatment for plaque psoriasis…... [Read More]

Filed Under: DMARDs & Immunosuppressives, Drug Updates Tagged With: dermatitis, dupilumab, FDA, halobetasol propionate lotion, plaque psoriasis, U.S. Food and Drug Administration (FDA)

Plaque Psoriasis Treatments: BMS-986165 Promising & Adalimumab Biosimilar Demonstrates Equivalence

October 22, 2018 • By Michele B. Kaufman, PharmD, BCGP

According to new data, BMS-986165, an oral, selective tyrosine kinase 2 inhibitor, may be safe and effective for treating plaque psoriasis…... [Read More]

Filed Under: Biologics & Biosimilars, DMARDs & Immunosuppressives, Drug Updates Tagged With: adalimumab, adalimumab-adbm, BMS-986165, plaque psoriasis, TYK2 inhibitor, tyrosine kinase 2 inhibitor

Piclidenoson in Trials for Psoriasis & RA; Plus Duzallo Approved in Europe

September 18, 2018 • By Michele B. Kaufman, PharmD, BCGP

New clinical trials are underway to determine the safety and efficacy of piclidenoson for patients with plaque psoriasis and rheumatoid arthritis…... [Read More]

Filed Under: DMARDs & Immunosuppressives, Drug Updates Tagged With: Duzallo, Europe, International, piclidenoson, Psoriasis, Rheumatoid Arthritis (RA)

Dietary Recommendations for Psoriasis Patients

August 2, 2018 • By Lara C. Pullen, PhD

The National Psoriasis Foundation says weight loss and other dietary interventions may benefit psoriasis patients. New recommendations note the benefits of a gluten-free diet for patients who test positive for gluten sensitivity, but also found little evidence to support the use of fish oil supplements for psoriasis patients…... [Read More]

Filed Under: Conditions Tagged With: Diet, dietary supplement, National Psoriasis Foundation (NPF), Psoriasis, recommendations

FDA Approves Combination Therapy for OA Pain, but Not Duobrii Lotion for Plaque Psoriasis

July 9, 2018 • By Michele B. Kaufman, PharmD, BCGP

The FDA has approved a combination of amlodipine and celecoxib, which may lower serum creatinine, for treating osteoarthritis pain and hypertension…... [Read More]

Filed Under: Analgesics, DMARDs & Immunosuppressives, Drug Updates Tagged With: Consensi, Duobrii, FDA approval, hypertension, osteoarthritis (OA), Pain, Pain Management, U.S. Food and Drug Administration (FDA)

Little Evidence to Support Most Dietary Interventions for Psoriasis

June 29, 2018 • By Marilynn Larkin

NEW YORK (Reuters Health)—New recommendations from the National Psoriasis Foundation Medical Board suggest that losing weight by following a low-calorie diet can reduce psoriasisseverity in overweight patients, but there is little evidence to support other dietary interventions. “Our psoriasis patients have long asked us about the role of diet on psoriasis,” Dr. April Armstrong of the… [Read More]

Filed Under: Conditions Tagged With: dietary intervention, low-calorie diet, National Psoriasis Foundation Medical Board, psoriasisseverity

Certolizumab Pegol Receives FDA Approval for Plaque Psoriasis

June 18, 2018 • By Michele B. Kaufman, PharmD, BCGP

On the basis of data from multiple clinical trials, the FDA has approved certolizumab pegol for treating moderate to severe plaque psoriasis…... [Read More]

Filed Under: DMARDs & Immunosuppressives, Drug Updates Tagged With: Certolizumab Pegol, FDA, FDA approval, plaque psoriasis, Psoriasis, U.S. Food and Drug Administration (FDA)

FDA Updates Ixekizumab Label to Include Genital Area Psoriasis

June 6, 2018 • By Michele B. Kaufman, PharmD, BCGP

Ixekizumab is the first agent approved by the FDA for treating plaque psoriasis to include labeling for psoriasis in the genital area…... [Read More]

Filed Under: Conditions, Drug Updates Tagged With: FDA, genital psoriasis, ixekizumab, Psoriasis, U.S. Food and Drug Administration (FDA)

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 43
  • Next Page »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

This site uses cookies: Find out more.